longbridge

Impact BioMedical

IBO
----

全部股東

股東類型

  • 上市公司86.56%
  • 公眾及其他7.10%
  • 機構投資者3.56%
  • 個人與內幕人士2.78%

主要股東

主要股東 最新
股東
DSS, Inc.
86.24%736.78 萬0.00%+0
Vanguard Capital Management, LLC
1.30%11.08 萬0.10%+8,300.0030/06/2026
Geode Capital Management, LLC
1.10%9.39 萬<0.01%-615.0030/06/2026
State Street Investment Management
0.56%4.82 萬0.00%+030/06/2026
Frank HeuszelChairman & CEO
0.46%3.93 萬0.00%+0
Alset Inc.
0.33%2.79 萬0.00%+0
Melissa SimsIndependent Director
0.28%2.38 萬0.00%+0
David KeeneIndependent Director
0.28%2.38 萬0.00%+0
Heng Fai ChanDirector
0.28%2.38 萬0.00%+0
Castel HibbertIndependent Director
0.28%2.38 萬0.00%+0
Elise BrownellIndependent Director
0.28%2.38 萬0.00%+0
Christian ZimmermanIndependent Director
0.28%2.38 萬0.00%+0
Mark SuseckChief Operating Officer
0.28%2.38 萬0.00%+0
BlackRock, Inc.
0.24%2.06 萬0.00%+030/06/2026
Jason GradyDirector
0.23%1.98 萬0.00%+023/03/2026
Northern Trust Global Investments
0.22%1.87 萬<0.01%-671.0030/06/2026
Todd MackoCFO, Secretary & Treasurer
0.14%1.23 萬0.00%+027/03/2026
Citadel Advisors LLC
0.05%3,927.00--+3,927.0030/06/2026
Vanguard Global Advisers, LLC
0.03%2,551.000.00%+030/06/2026
Jane Street Group, LLC
0.02%1,943.000.02%+1,943.0030/06/2026
© 2026 Longbridge｜服務條款隱私政策